Mechanisms of tolvaptan-induced toxicity in HepG2 cells

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works

Autophagy in the Pathogenesis of Disease

Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · see citing works

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · see citing works

DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139

Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · see citing works

Induction of the Vitamin D Receptor Attenuates Autophagy Dysfunction-Mediated Cell Death Following Traumatic Brain Injury

Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, R. C., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,214 · see citing works

Mammalian MAP kinase signalling cascades

Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118 · see citing works

Cell Death

Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651 · see citing works

Methods in Mammalian Autophagy Research

Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497 · see citing works

Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis

Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445 · see citing works

Autophagy and Viruses: Adversaries or Allies?

Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,441 · see citing works

BCL-2 family members and the mitochondria in apoptosisPreprint

Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,623 · see citing works

Apoptosis: controlled demolition at the cellular level

Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,617 · see citing works

Mitochondria and cell death: outer membrane permeabilization and beyond

Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593 · see citing works

Impairment of starvation-induced and constitutive autophagy in <i>Atg7</i> -deficient mice

Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · see citing works

Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells

Ikeda, R., Che, X., Yamaguchi, T., Ushiyama, M., Zheng, C., Okumura, H., Takeda, Y., Shibayama, Y., Nakamura, K. T., Jeung, H., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00057.x · Cited by 2,268 · see citing works

Cell cycle checkpoint signaling through the ATM and ATR kinases

Abraham, R. T. (2001) · Genes &amp; Development · doi:10.1101/gad.914401 · Cited by 1,966 · see citing works

Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation

Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. J. W. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,867 · see citing works

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

Vermeulen, K., Bockstaele, D. R. V., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,766 · see citing works

BCL-2 FAMILY: Regulators of Cell Death

Chao, D. T., & Korsmeyer, S. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.395 · Cited by 1,686 · see citing works

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Grantham, J. J., Higashihara, E., Perrone, R. D., Krasa, H. B., Ouyang, J., & Czerwiec, F. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205511 · Cited by 1,621 · see citing works

Drug-induced hepatotoxicity

Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594 · see citing works

Ubiquitin ligases: cell-cycle control and cancer

Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,441 · see citing works

Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics

Martinou, J., & Youle, R. J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.06.017 · Cited by 1,366 · see citing works

Tolvaptan, a Selective Oral Vasopressin V ₂ -Receptor Antagonist, for Hyponatremia

Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065181 · Cited by 1,215 · see citing works

Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis

Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,118 · see citing works

The comet assay: topical issues

Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivão, I., Giovannelli, L., Kruszewski, M. K., Smith, C. C., & Štětina, R. (2008) · Mutagenesis · doi:10.1093/mutage/gem051 · Cited by 991 · see citing works

Autophagy: dual roles in life and death?

Baehrecke, E. H. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1666 · Cited by 986 · see citing works

MAP Kinase PathwaysPreprint

Morrison, D. K. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011254 · Cited by 846 · see citing works

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

Chen, D., Frezza, M., Schmitt, S. M., Kanwar, J., & Dou, Q. P. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519752 · Cited by 796 · see citing works

Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases

Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., & Sassone‐Corsi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.874-885.2002 · Cited by 668 · see citing works

The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions

Keshet, Y., & Seger, R. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-795-2_1 · Cited by 642 · see citing works

Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis

Kim, H., Tu, H.-C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.030 · Cited by 600 · see citing works

Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle

Ekholm, S. V., & Reed, S. I. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00151-4 · Cited by 587 · see citing works

Pyridinyl Imidazole Inhibitors of p38 Mitogen-activated Protein Kinase Bind in the ATP Site

Young, P. R., McLaughlin, M. M., Kumar, S., Kassis, S., Doyle, M. L., McNulty, D. E., Gallagher, T. F., Fisher, S., McDonnell, P., Carr, S. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12116 · Cited by 570 · see citing works

Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury

Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J., & de Graaf, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn109 · Cited by 494 · see citing works

Adverse drug reactions in elderly patients

Routledge, P. A., O'Mahony, M. S., & WOODHOUSE, K. W. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01875.x · Cited by 491 · see citing works

p53 regulates a G 2 checkpoint through cyclin B1

Innocente, S. A., Abrahamson, J., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 435 · see citing works

Activation of Autophagy Protects Against Acetaminophen–Induced Hepatotoxicity

Ni, H., Bockus, A. B., Boggess, N., Jaeschke, H., & Ding, W. (2011) · Hepatology · doi:10.1002/hep.24690 · Cited by 429 · see citing works

The role of the ubiquitin-proteasome pathway in apoptosis

Orlowski, R. Z. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400505 · Cited by 385 · see citing works

Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes

Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348 · see citing works

Differential Inhibition of Calpain and Proteasome Activities by Peptidyl Aldehydes of Di-Leucine and Tri-Leucine

Tsubuki, S., Saito, Y., Tomioka, M., Itô, H., & Kawashima, S. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021280 · Cited by 308 · see citing works

MEK1/2 dual-specificity protein kinases: Structure and regulation

Roskoski, R. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.145 · Cited by 277 · see citing works

Ubiquitin Ligases and Cell Cycle Control

Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 253 · see citing works

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

Frémin, C., & Meloche, S. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-8 · Cited by 243 · see citing works

Cleavage of Bax Enhances Its Cell Death Function

Wood, D. E., & Newcomb, E. W. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4859 · Cited by 215 · see citing works

In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone

Dykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., Smith, A. R., & Will, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn056 · Cited by 195 · see citing works

Utilizing flow cytometry to monitor autophagy in living mammalian cells

Shvets, E., Fass, E., & Elazar, Z. (2008) · Autophagy · doi:10.4161/auto.5939 · Cited by 163 · see citing works

Cadmium telluride quantum dots cause oxidative stress leading to extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2 cells

Nguyen, K. C., Willmore, W. G., & Tayabali, A. F. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.010 · Cited by 155 · see citing works

Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review

Dorne, J. L. C. M., Walton, K., & RENWICK, A. G. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.05.011 · Cited by 128 · see citing works

Regulation of apoptosis by the ubiquitin and proteasome pathway

Wójcik, C. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00309.x · Cited by 118 · see citing works

Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways

Chen (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.922 · Cited by 115 · see citing works

Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone

Felser, A., Blum, K., Lindinger, P. W., Bouitbir, J., & Krähenbühl, S. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs298 · Cited by 109 · see citing works

Millepachine, a novel chalcone, induces G 2 /M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo

Wu, W., Ye, H., Wan, L., Han, X., Wang, G., Hu, J., Tang, M., Duan, X., Fan, Y., He, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt087 · Cited by 105 · see citing works

Carfilzomib: A Novel Second-Generation Proteasome Inhibitor

Khan, M. L., & Stewart, A. K. (2011) · Future Oncology · doi:10.2217/fon.11.42 · Cited by 90 · see citing works

Cell based approaches for evaluation of drug-induced liver injury

Greer, M. L., Barber, J., Eakins, J. A., & Kenna, J. G. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.007 · Cited by 73 · see citing works

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non‐peptide AVP antagonist in healthy subjects

Shoaf, S. E., Bricmont, P., & Mallikaarjun, S. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04114.x · Cited by 72 · see citing works

Sertraline induces endoplasmic reticulum stress in hepatic cells

Chen, S., Xuan, J., Couch, L. H., Iyer, A., Wu, Y., Li, Q., & Guo, L. (2014) · Toxicology · doi:10.1016/j.tox.2014.05.007 · Cited by 66 · see citing works

Long-Term Exposure to Zidovudine Delays Cell Cycle Progression, Induces Apoptosis, and Decreases Telomerase Activity in Human Hepatocytes

Fang, J., & Beland, F. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp136 · Cited by 65 · see citing works

Involvement of enniatins-induced cytotoxicity in human HepG2 cells

Juan‐García, A., Manyes, L., Ruiz, M.-J., & Font, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.01.014 · Cited by 57 · see citing works

Pharmacokinetics, Pharmacodynamics and Safety of Tolvaptan, A Novel, Oral, Selective Nonpeptide AVP V2-receptor Antagonist: Results of Single- and Multiple-Dose Studies in Healthy Japanese Male Volunteers

Kim, S. R., Hasunuma, T., Satō, O., Okada, T., Kondo, M., & Azuma, J. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6299-3 · Cited by 56 · see citing works

The Role of Autophagy in Usnic Acid-Induced Toxicity in Hepatic Cells

Chen, S., Dobrovolsky, V. N., Liu, F., Wu, Y., Zhang, Z., Mei, N., & Guo, L. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu154 · Cited by 56 · see citing works

Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan

Friedman, B. C., & Cirulli, J. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.06.001 · Cited by 51 · see citing works

Autophagy as a rescue mechanism in Efavirenz-induced mitochondrial dysfunction: A lesson from hepatic cells

Apostolova, N., Gómez-Sucerquia, L. J., Gortat, A., Blas‐García, A., & Esplugues, J. V. (2011) · Autophagy · doi:10.4161/auto.7.11.17653 · Cited by 35 · see citing works

Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects

Shoaf, S. E., Kim, S. R., Bricmont, P., & Mallikaarjun, S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1295-5 · Cited by 31 · see citing works

Autophagy in drug-induced liver toxicity

Chen, S., Melchior, W. B., Wu, Y., & Guo, L. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.03.007 · Cited by 27 · see citing works

Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects

Shoaf, S. E., Mallikaarjun, S., & Bricmont, P. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1106-4 · Cited by 26 · see citing works

Extracellular signal-regulated kinases 1/2 and Akt contribute to triclosan-stimulated proliferation of JB6 Cl 41-5a cells

Wu, Y., Beland, F. A., Chen, S., & Fang, J. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1308-5 · Cited by 23 · see citing works

Differential effects of triclosan on the activation of mouse and human peroxisome proliferator-activated receptor alpha

Wu, Y., Wu, Q., Beland, F. A., Ge, P., Manjanatha, M. G., & Fang, J. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.001 · Cited by 22 · see citing works

Identification of BC005512 as a DNA Damage Responsive Murine Endogenous Retrovirus of GLN Family Involved in Cell Growth Regulation

Wu, Y., Qi, X., Gong, L., Xing, G., Chen, M., Miao, L., Yao, J., Suzuki, T., Furihata, C., Luan, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035010 · Cited by 14 · see citing works

Estrogen and Progesterone Lower Cyclin B1 and D1 Expression, Block Cell Cycle in G2/M, and Trigger Apoptosis in Human Adrenal Carcinoma Cell Cultures

Brown, J. B., Prieto, L. M., Perez‐Stable, C., Montoya, M., Cappell, S. D., & Fishman, L. M. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1073140 · Cited by 10 · see citing works

Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis

Cui, Y., Lu, P., Song, G., Liu, Q., Zhu, D., & Liu, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.013 · Cited by 94 · see citing works

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors

Woodhead, J. L., Brock, W. J., Roth, S. E., Shoaf, S. E., Brouwer, K. L. R., Church, R. J., Grammatopoulos, T. N., Stiles, L., Siler, S. Q., Howell, B. A., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw193 · Cited by 92 · see citing works

Drug rechallenge following drug‐induced liver injury

Hunt, C. M., Papay, J. I., Stanulović, V., & Regev, A. (2017) · Hepatology · doi:10.1002/hep.29152 · Cited by 76 · see citing works

Real‐life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion

Tzoulis, P., Waung, J. A., Bagkeris, E., Carr, H., Khoo, B. C. E., Cohen, M., & Bouloux, P. M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12943 · Cited by 68 · see citing works

M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma

Guo, B., Li, L., Guo, J., Liu, A., Wu, J., Wang, H., Shi, J., Pang, D., & Cao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17973 · Cited by 66 · see citing works

miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model

Mosedale, M., Eaddy, J. S., Trask, O. J., Holman, N. S., Wolf, K., LeCluyse, E. L., Ware, B. R., Khetani, S. R., Lu, J., Brock, W. J., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx206 · Cited by 56 · see citing works

Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?

Slizgi, J. R., Lu, Y., Brouwer, K. R., St. Claire, R. L., Freeman, K. M., Pan, M., Brock, W. J., & Brouwer, K. L. R. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfv231 · Cited by 53 · see citing works

Editor’s Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach

Mosedale, M., Kim, Y., Brock, W. J., Roth, S. E., Wiltshire, T., Eaddy, J., Keele, G. R., Corty, R., Xie, Y., Valdar, W., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw269 · Cited by 53 · see citing works

A metabolically stable apelin-17 analog decreases AVP-induced antidiuresis and improves hyponatremia

Flahault, A., Girault-Sotias, P.-E., Keck, M., Alvear‐Perez, R., Mota, N. D., Estéoulle, L., Ramanoudjame, S. M., Iturrioz, X., Bonnet, D., & Llorens‐Cortés, C. (2021) · Nature Communications · doi:10.1038/s41467-020-20560-y · Cited by 35 · see citing works

Study on the Mechanism of Mesaconitine-Induced Hepatotoxicity in Rats Based on Metabonomics and Toxicology Network

Chen, Q., Zhang, K., Jiao, M., Jiao, J., Chen, D., Yin, Y., Zhang, J., & Li, F. (2022) · Toxins · doi:10.3390/toxins14070486 · Cited by 33 · see citing works

Apelin and Vasopressin: The Yin and Yang of Water Balance

Girault-Sotias, P.-E., Gerbier, R., Flahault, A., Mota, N. D., & Llorens‐Cortés, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735515 · Cited by 33 · see citing works

Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells

Ren, Z., Chen, S., Zhang, J., Doshi, U., Li, A. P., & Guo, L. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw173 · Cited by 29 · see citing works

Autophagy in drug-induced liver toxicity

Chen, S., Melchior, W. B., Wu, Y., & Guo, L. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.03.007 · Cited by 27 · see citing works

Tolvaptan-induced Liver Injury: Who is at Risk? A Case Report and Literature Review

Khan, M. Y., Rawala, M. S., Siddiqui, M., Abid, W., & Aslam, A. (2019) · Cureus · doi:10.7759/cureus.4842 · Cited by 23 · see citing works

Hyponatremia and Cancer: From Bedside to Benchside

Fibbi, B., Marroncini, G., Naldi, L., Anceschi, C., Errico, A., Norello, D., & Peri, A. (2023) · Cancers · doi:10.3390/cancers15041197 · Cited by 21 · see citing works

Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells

Marroncini, G., Anceschi, C., Naldi, L., Fibbi, B., Baldanzi, F., Martinelli, S., Polvani, S., Maggi, M., & Peri, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111419 · Cited by 20 · see citing works

Human Sulfotransferases Enhance the Cytotoxicity of Tolvaptan

Fang, J., Wu, Y., da Costa, G. G., Chen, S., Chitranshi, P., & Beland, F. A. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv311 · Cited by 17 · see citing works

How impaired efficacy happened between Gancao and Yuanhua: Compounds, targets and pathways

Yu, J., Guo, J., Zhu, K. Y., Tao, W., Chen, Y., Liu, P., Hua, Y., Tang, Y., & Duan, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03201-1 · Cited by 17 · see citing works

Protective mechanisms of purified polyphenols from pinecones of Pinus koraiensis on spleen tissues in tumor-bearing S180 mice in vivo

Yi, J., Cheng, C., Li, X., Zhao, H., Qu, H., Wang, Z., & Wang, L. (2016) · Food & Function · doi:10.1039/c6fo01235c · Cited by 12 · see citing works

Shedding Light on Drug-Induced Liver Injury: Activation of T Cells From Drug Naive Human Donors With Tolvaptan and a Hydroxybutyric Acid Metabolite

Hammond, S., Gibson, A., Jaruthamsophon, K., Roth, S. E., Mosedale, M., & Naisbitt, D. J. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa157 · Cited by 12 · see citing works

Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning

Meshkani, S. E., Mahdian, D., Abbaszadeh‐Goudarzi, K., Abroudi, M., Dadashizadeh, G., Lalau, J., Broe, M. E. D., & Hosseinzadeh, H. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01060-3 · Cited by 12 · see citing works

Predictors of tolvaptan short‐term response in patients with refractory ascites: A meta‐analysis

Bellos, I., Kontzoglou, K., & Perrea, D. N. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14784 · Cited by 11 · see citing works

Hepatocrinology

Kalra, S., Bhattacharya, S., & Rawal, P. (2021) · Medical Sciences · doi:10.3390/medsci9020039 · Cited by 11 · see citing works

The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells

Marroncini, G., Anceschi, C., Naldi, L., Fibbi, B., Baldanzi, F., Maggi, M., & Peri, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01807-5 · Cited by 7 · see citing works

The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer

Naldi, L., Fibbi, B., Polvani, S., Cirillo, C., Pasella, F., Bartolini, F., Romano, F., Fanelli, A., Peri, A., & Marroncini, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158402 · Cited by 6 · see citing works

The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease

Kotlyarova, A., Iskrina, A., & Kotlyarov, S. (2026) · International journal of molecular sciences · doi:10.3390/ijms27083399 · Cited by 5 · see citing works

Synthetic routes and clinical application of new drugs approved by EMA during 2023

Xia, Y., Chen, Q., Liu, H., Chi, Y., Zhu, Y., Shan, L., Dai, B., Wu, L., & Shi, X. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116762 · Cited by 5 · see citing works

Antiproliferative effects of dihydrotanshinone I on autosomal dominant polycystic kidney disease via immunomodulation

Mahendran, R., Lim, S. K., Ong, K. C., Chua, K. H., & Chai, H. C. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103655 · Cited by 5 · see citing works

MD simulation-based screening approach identified tolvaptan as a potential inhibitor of Eg5

Sebastian, J., Raghav, D., & Rathinasamy, K. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10482-w · Cited by 5 · see citing works

Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities

Hammond, S., Meng, X., Barber, J., Mosedale, M., Chadwick, A. E., Watkins, P. B., & Naisbitt, D. J. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae142 · Cited by 5 · see citing works

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model

Tanabe, N., Takami, T., Fujisawa, K., Matsumoto, T., Yamamoto, N., & Sakaida, I. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-122 · Cited by 4 · see citing works

Sulfotransferases

Duffel, M. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00005-x · Cited by 3 · see citing works

Sulfotransferases

Duffel, M. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95623-x · Cited by 2 · see citing works

Hyponatraemia and cancer

Naldi, L., Fibbi, B., Marroncini, G., Norello, D., & Peri, A. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102066 · Cited by 1 · see citing works

Can tolvaptan usage cause cytotoxicity? An in vitro study

Erdem, B. (2022) · The European Research Journal · doi:10.18621/eurj.1058030 · Cited by 1 · see citing works

Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases

Uno, T., Hosomi, K., & Yokoyama, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-77052-y · Cited by 1 · see citing works

The Delay of Tolvaptan-induced Liver Injury in an Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patient: A Case Report

Sasaki, R., Kanda, T., Honda, M., Takahashi, H., Kaneko, T., Yamana, Y., Kumagawa, M., Ishii, T., Mizutani, T., Masuzaki, R., et al. (2021) · Kanzo · doi:10.2957/kanzo.62.72 · Cited by 1 · see citing works

DRUG-INDUCED LIVER INJURY: A PREDICTIVE MODEL, MITOCHONDRIAL TOXICITY MECHANISMS RISK, AND ANTIPSYCHOTIC MEDICATIONS RISK IN A REAL-WORLD SETTING

Rana, P. (2020) · doi:10.23860/rana-payal-2020

Iponatriemia e cancro

Norello, D., Naldi, L., Peri, A., & Fibbi, B. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01566-4

TLR4 knockout ameliorates acute LPS-sensitized tolvaptan-induced idiosyncratic liver injury by disrupting drug metabolism, inflammation, and bile acid homeostasis

Jiang, X., Hu, Y.-X., Cheng, B., Hu, J., Zhao, Y.-Q., Wu, S., Li, H., Gong, L.-M., Feng, G., Li, D., et al. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116113

Species, cell proliferation state and oxygen partial pressure are major factors in the in vitro toxicity of repurposed potential ADPKD drugs in human and murine renal proximal tubule cells

Sotiropoulou, P., Gerdemann, A., Jovanovic, S., Humpf, H.-U., Bürkle, A., & Dietrich, D. R. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04472-2

Can tolvaptan usage cause cytotoxicity? An in vitro study

Erdem, B. (2022) · The European Research Journal · doi:10.18621/eurj.1058030 · Cited by 1 · see citing works

Sulfonate and acetyl derivatives of the vasopressin antagonist tolvaptan: reactivity towards DNA and 2’-deoxynucleosides

Fidalgo, L. G. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors

Woodhead, J. L., Brock, W. J., Roth, S. E., Shoaf, S. E., Brouwer, K. L. R., Church, R. J., Grammatopoulos, T. N., Stiles, L., Siler, S. Q., Howell, B. A., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw193 · Cited by 92 · see citing works

Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress

Zhou, G., Qin, M., Zhang, X., Yang, J., & Yu, H. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2020.05.011 · Cited by 1 · see citing works

Effects of topotecan on the proliferation and apoptosis of human hepatocarcinoma cell line HepG2 in vitro

Kai-xi, T. (2003) · Chongqing yixue